Azathioprine induced liver disease: Nodular regenerative hyperplasia of the liver and perivenous fibrosis in a patient treated for multiple sclerosis

Gut

Volumn 32, Issue 6, 1991, Pages 715-717

  Mion, F ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE;

ADULT; ARTICLE; CASE REPORT; HUMAN; LIVER FIBROSIS; LIVER HYPERPLASIA; LIVER TOXICITY; LIVER VEIN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ADULT; AZATHIOPRINE; CASE REPORT; HUMAN; HYPERPLASIA; LIVER; LIVER CIRRHOSIS; MALE; MULTIPLE SCLEROSIS;

EID: 0025772875     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.32.6.715     Document Type: Article

References (5)

1. Haxhe JJ, Alexander GPJ, Kestcns PJ. The effect of Imuran and Azaserine on liver function tests in the dog. Arch Intern Pharmacodyn 1967;168: 366-72.
2. Sopko J, Anuras S. Liver disease in renal transplant recipients. Am J Med 1978 64: 139-46.
3. De Pinho RA, Goldberg CS, Lefkowitch JH. Azathioprine and the liver. Evidence favoring idiosyncratic, mixed cholestatic-hepatocellular injury in humans. Gastroenterology 1984; 86: 162-5.
4. Sparberg M, Simon N, Del Greco F. Intrahepatic cholestasis due to azathioprine. Gastroterology 1969; 57: 439-11.
5. Degott C, Rueff B, Kreis H, Duboust A, Potet F, Benhamou JP. Peliosis hepatis in recipients of renal transplants. Gut 1978; 19: 748-53.